Fluoroquinolone and Other Antimicrobial Resistance in Invasive Pneumococci, Hong Kong, 1995–2001
Pak-Leung Ho* , Tak-Lun Que†, Susan S. Chiu*, Raymond W. H. Yung†, Tak-Keung Ng§, Dominic N. C. Tsang¶, Wing-Hong Seto*, and Yu-Lung Lau*
Author affiliations: *Queen Mary Hospital, The University of Hong Kong, Hong Kong Special Administrative Region (SAR), China; †Tuen Mun Hospital, Hong Kong SAR, China; ‡Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China; §Princess Margaret Hospital, Hong Kong, SAR, China; ¶Queen Elizabeth Hospital, Hong Kong SAR, China
Figure 2. HinfI fingerprints of the pbp genes. A) pbp2b profiles. Lanes 1, marker; 2, Spain23F-1 clone (SP264, ATCC 700669); 3, a ciprofloxacin-resistant, levofloxacin-susceptible strain S1D3; 4, Spain6B clone (GM17, ATCC 700670); lane 5−14, 10 isolates of levofloxacin_resistant pneumococci (S3F7, S2H9, S1B7, S1B9, S1D5, S2D6, S1D2, S2F3, 186G1, and 216D2 respectively); B) pbp2x profiles. The lanes were arranged in the same sequence as in (A).
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.